What is she best known for?
The fields of study she is best known for:
- Immune system
- Cancer
- T cell
Her scientific interests lie mostly in Interleukin 12, Interleukin 21, Lymphokine-activated killer cell, Immunology and Cell biology.
Her work on Interleukin 12 is being expanded to include thematically relevant topics such as Natural killer T cell.
Her Interleukin 21 research focuses on subjects like Antigen-presenting cell, which are linked to Human leukocyte antigen and Dendritic cell.
Her research investigates the connection with Lymphokine-activated killer cell and areas like Janus kinase 3 which intersect with concerns in Monoclonal, Cytolysis, Cell Maturation and NK Cell Lectin-Like Receptor Subfamily D.
Her work in Immunology addresses subjects such as Natural killer cell, which are connected to disciplines such as Cancer research.
Her Cell biology study incorporates themes from Receptor, Stromal cell, Natural Cytotoxicity Triggering Receptor 1 and Cytotoxicity.
Her most cited work include:
- Identification and Molecular Characterization of Nkp30, a Novel Triggering Receptor Involved in Natural Cytotoxicity Mediated by Human Natural Killer Cells (687 citations)
- NKp44, a Novel Triggering Surface Molecule Specifically Expressed by Activated Natural Killer Cells, Is Involved in Non–Major Histocompatibility Complex–restricted Tumor Cell Lysis (647 citations)
- Transforming growth factor β1 inhibits expression of NKp30 and NKG2D receptors: Consequences for the NK-mediated killing of dendritic cells (476 citations)
What are the main themes of her work throughout her whole career to date?
Her primary scientific interests are in Immunology, Interleukin 12, Interleukin 21, Cell biology and Immune system.
Her Immunology study frequently links to adjacent areas such as Natural killer cell.
Follicular dendritic cells and Chemokine is closely connected to Natural killer T cell in her research, which is encompassed under the umbrella topic of Interleukin 12.
She has researched Interleukin 21 in several fields, including Cytolysis and Antigen-presenting cell.
The concepts of her Cell biology study are interwoven with issues in Receptor, Natural Cytotoxicity Triggering Receptor 1 and Chemokine receptor.
Her Immune system research includes elements of Cancer, Cancer research, Cytokine and Virus, Virology.
She most often published in these fields:
- Immunology (51.79%)
- Interleukin 12 (40.18%)
- Interleukin 21 (38.39%)
What were the highlights of her more recent work (between 2017-2021)?
- Cancer research (20.54%)
- Immune system (30.36%)
- Cell biology (37.50%)
In recent papers she was focusing on the following fields of study:
Emanuela Marcenaro focuses on Cancer research, Immune system, Cell biology, Immunotherapy and Innate lymphoid cell.
As part of the same scientific family, Emanuela Marcenaro usually focuses on Immune system, concentrating on Human leukocyte antigen and intersecting with Effector and Cytotoxicity.
Her Cell biology research is multidisciplinary, incorporating perspectives in Inflammation, Endothelial activation, Downregulation and upregulation and Peripheral blood.
Her Innate lymphoid cell research entails a greater understanding of Receptor.
Her research investigates the connection between Receptor and topics such as NKG2D that intersect with issues in Lymphocyte.
Her Innate immune system study results in a more complete grasp of Immunology.
Between 2017 and 2021, her most popular works were:
- PD/1-PD-Ls checkpoint: Insight on the potential role of NK cells (53 citations)
- PD-1 in human NK cells: evidence of cytoplasmic mRNA and protein expression. (37 citations)
- The early expansion of anergic NKG2Apos/CD56dim/CD16neg natural killer represents a therapeutic target in haploidentical hematopoietic stem cell transplantation. (35 citations)
In her most recent research, the most cited papers focused on:
- Immune system
- T cell
- Cancer
Emanuela Marcenaro spends much of her time researching Immune system, Cancer research, Receptor, Tumor microenvironment and Innate lymphoid cell.
Her Immune system study frequently intersects with other fields, such as Human leukocyte antigen.
To a larger extent, she studies Immunology with the aim of understanding Human leukocyte antigen.
Emanuela Marcenaro interconnects T cell, Innate immune system, Monoclonal antibody, Transplantation and Immunotherapy in the investigation of issues within Cancer research.
Her study in Receptor is interdisciplinary in nature, drawing from both Natural killer cell, Hematopoietic stem cell transplantation, Lymphocyte and NKG2D.
She focuses mostly in the field of Innate lymphoid cell, narrowing it down to matters related to Cell biology and, in some cases, Peripheral tolerance.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
